We have investigated the response of T cells to staphylococcal enterotoxin A (SEA) injections in vivo. We found that a single injection of SEA with an optimal dose of 10 μg increased the expression of both CD4 and CD8 significantly. There was expansion of SEA-reactive T cells in vivo after SEA re-injection and the time interval between injections strongly influenced the responsiveness of CD4 + and CD8 + T cells. Anergy of T cells was observed after three SEA treatments. The time interval between injections mainly affected the unresponsiveness of CD4 + T cells, not CD8 + T cells. Marked deletion followed by anergy of CD4 + T cells was induced at short intervals, and anergy without obvious deletion of CD4 + T cells was induced at long intervals. We also found that the anergic state was reversible in vivo. Repeated SEA stimulation led to down-regulation of interleukin (IL)-2, and high levels of IL-10. This study showed that both CD4 + and CD8 + SEA-primed T cells were responsive to SEA rechallenge in vivo, and a third injection was needed to induce the anergy of T cells.
Superantigens are bacterial and viral proteins that bind directly to major histocompatibility complex (MHC) class II molecules without being processed and subsequently activate T cells expressing specific T cell receptor Vβ chains [1, 2] . Previous studies have shown that exposure of peripheral T cells to staphylococcal enterotoxin A (SEA) or staphylococcal enterotoxin B (SEB) results in the expansion of CD4 + and CD8 + T cells, and production of cytokines such as interleukin (IL)-2, interferon-γ and tumor necrosis factor-α [3−5] . Superantigens also direct cytolytic T cells to kill MHC class II-expressing target cells [6, 7] . Apart from their strong ability to activate T cells, superantigens were reported to induce a subsequent state of unresponsiveness characterized by anergy in the remaining T cells [8−10] . Anergy is one of the mechanisms of tolerance, typified by unresponsiveness of T cells and poor IL-2 production [11, 12] . This property of superantigens strongly limits their antitumor therapy effect.
The response of T cells induced by superantigens has been studied extensively, however, there are few published reports about the relationship between the induction of anergy and repeated superantigen treatments at different time intervals. This study was undertaken to evaluate the responses of T cells to SEA injections at different intervals in vivo. We found a third injection was needed to induce the anergy of T cells, and the time interval between injections played an important role in the response of CD4 + and CD8 + T cells.
Materials and Methods

Animals and treatment
Eight to ten-week-old C57BL/6 mice (H-2 b ) were purchased from the Experimental Animal Center of the Fourth Military Medical University (Xi'an, China). Mice were housed in microisolation in a dedicated, pathogen-free facility, and all animal experimentation was conducted in accordance with animal ethics guidelines. Mice were injected once intraperitoneally (i.p.) with different doses Vol. 39, No. 7 ©Institute of Biochemistry and Cell Biology, SIBS, CAS of SEA in 0.2 ml phosphate-buffered saline (PBS). The optimal dose of SEA was injected i.p. repeatedly to mice at different time intervals. Control mice received the same volume of PBS.
Proliferation assays
Proliferation of spleen cells was detected by 3 H-TdR assay. Spleens were removed from SEA-primed or PBSprimed mice and single-cell suspensions were prepared and cultured (10 6 cells/well) in 100 μl of culture medium (RPMI 1640 supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin, 1% sodium pyruvate, 10% fetal calf serum of 10 −5 M mercaptoethanol) at 37 ºC with 5% CO 2 . 
Antibodies and fluorescence-activated cell sorting analysis
The antibodies used for flow cytometry, anti-CD4-phycoerithrin (PE), anti-CD8-PE, anti-IL-2-PE, anti-IL-10-PE and anti-CD3-fluorescein-isothiocyanate, were purchased from Biolegend (San Diego, USA). Samples were stained and analyzed on a FACSCalibur cytometer using CellQuest software (BD Biosciences, Becton, USA). For analysis of intracellular IL-2 and IL-10, cells were fixed with 2% paraformaldehyde and permeabilized using 0.5% saponin before staining.
Cytokine assays
The samples of serum were collected at various time points after SEA treatments in vivo, and were stored at −70 ºC until tested for cytokine content. The levels of IL-2 and IL-10 in sera were measured with sandwich enzyme-linked immunosorbent assay kits (Sigma, USA) according to the manufacturer's instructions.
Statistical analysis
One-way ANOVA was used to determine differences in immune responses among the various treatment groups. Newman-Keuls tests were carried out as post-hoc analysis for one-way ANOVA. A P value of less than 0.05 was considered significant.
Results
Responses of T-cell subsets after single SEA challenge in vivo
In order to choose the optimal dose of SEA in vivo, spleen cells were analyzed for the expression of CD4 and CD8 after mice were injected i.p. with different doses of SEA (Fig. 1) . The results showed that there were obvious increases of the two subsets during the first 14 d after different doses of SEA challenge except 1 μg. The most efficient dose of SEA was 10 μg, which led to a significant up-regulation of CD4 and CD8 expressions from day 7 to day 14 after injection. The ratio of CD4 and CD8 after SEA challenge was similar to the ratio before SEA challenge,
Fig. 1 Expression of CD4 and CD8 T cells after single injection of staphylococcal enterotoxin A (SEA) in vivo
Mice were given an intraperitoneal injection of different doses of SEA or phosphate-buffered saline (control). Spleens were removed on different days after SEA injection and spleen cells were double stained with anti-CD4 or anti-CD8 monoclonal antibodies in combination with anti-CD3 monoclonal antibody for fluorescence-activated cell sorting analysis. The results are from three independent experiments, with three mice used in each experiment. *P<0.01 compared to the same day in the control group.
which showed the strong proliferative response of both CD4 + T cells and CD8 + T cells stimulated by SEA. To examine whether the primed T cells in vivo have proliferative capability, spleens were removed at different days after SEA injection and the spleen cells were restimulated with SEA (100 ng/ml) in vitro (Fig. 2) . Proliferation of the primed T cells was seen (SI>2), but it was clearly lower than that of the control. We also found that the proliferative capability could be gradually recovered. After 28 d, the responsiveness of the primed cells was similar to that of the control.
Expansion of CD4
+ and CD8 + T cells after two SEA injections SEA was injected twice i.p. at different time intervals, and the responses of T cells in spleen were analyzed (Fig.  3) . We found that there was still expansion of SEA-reactive T cells in vivo after SEA re-injection. However, the interval between SEA injections resulted in different expressions of CD4 and CD8. The peak of CD4 appeared at day 3 (3 d and 7 d intervals) and at day 7 (14, 21 and 28 d intervals), whereas the peak of CD8 only appeared at day 7. The interval between two injections led to different ratios of CD4 and CD8. The ratio decreased from approximately 1.35 to 1.15 10 d after SEA injections at short intervals (3 d and 7 d), but the ratio was not changed at long intervals (such as 28 d).
Anergy of CD4 + and CD8 + T cells induced by multiple SEA injections
To analyze the influence of the number of SEA injections on the induction of T cell anergy, mice were injected i.p. three times at different time intervals (Fig. 4) . Although unresponsiveness of T cells was observed following SEA treatments, CD4 expressions at short intervals were much lower than those at long intervals. The expression of CD8 was not significantly affected by the interval. These data suggested that the time of interval between injections mainly affected the unresponsiveness of CD4 + T cells, not CD8 + T cells. Marked deletion followed by anergy of CD4 + T cells was induced at short intervals, and anergy without obvious deletion of CD4 + T cells was induced at long intervals.
In an attempt to evaluate the changes of the unrespon-
Fig. 2 Staphylococcal enterotoxin A (SEA)-primed spleen cells in response to SEA stimulation in vitro
Mice were given an intraperitoneal injection of 10 μg SEA. Spleens were removed at different days after SEA injection and the spleen cells were cultured for 72 h with 100 ng/ml SEA in vitro. The proliferation was detected by 3 H-TdR assay. Only a stimulation index (SI)≥2 was considered to be significant proliferation. The control was normal spleen cells stimulated with SEA. The results are from three independent experiments, with three mice used in each experiment. *P<0.01 as the control compared to 1−14 d after SEA injection; # P<0.05 as the control compared to day 21 after SEA injection.
Fig. 3 Effects of time interval on T cells after two staphylococcal enterotoxin A (SEA) injections
Mice were injected twice intraperitoneally with 10 μg of SEA at different time intervals. Spleens were removed on different days after last injection and spleen cells were double stained with anti-CD4 or anti-CD8 monoclonal antibodies in combination with anti-CD3 monoclonal antibody for fluorescence-activated cell sorting analysis. The results are from three independent experiments, and three mice were used in each experiment. HTdR assay (Fig. 5) . We found that the partial responsiveness appeared at day 28 after the last injection with the 3 d interval, and at day 21 with the 7 d and 14 d interval. However, there was no significant proliferative response (SI<2) until 28 d after the last injection with the 21 d and 28 d interval.
IL-2 and IL-10 levels after repeated SEA injections
It is well established that T-cell anergy is associated with a failure to produce IL-2 [9, 13] and early studies have suggested that anti-inflammatory cytokine IL-10 was completely dominating the immune response after repeated SEA injections [14, 15] , which led us to examine the levels of IL-2 and IL-10 after SEA treatments and describe the anergic state in vivo. Large amounts of IL-2 were released in serum and maximal production was observed 3 h after a single SEA injection, whereas IL-10 in serum was almost undetected. The second SEA challenge given 3 d later resulted in lower levels of IL-2 in serum, but significant levels of IL-10 were observed. Higher IL-10 levels and almost no IL-2 production were seen after the third stimulation [ Fig. 6(A,B) ]. To investigate the relationship between the IL-10 production and the times of SEA treatments, we analyzed the levels of IL-10 in serum after repeated SEA injections. High IL-10 production was induced by repeated SEA injections, and the fourth SEA challenge resulted in the highest level of IL-10 [ Fig. 6(C) ].
To determine whether the serum levels were in accordance with the content of T cells, intracellular levels of both cytokines were analyzed. An obvious up-regulation of intracellular IL-2 could be observed as early as day 3 after the SEA injection, but the expression of IL-10 in T cells was very low. The level of IL-2 in cells went on increasing and the peak appeared at day 7 following two injections; at the same time intracellular IL-10 began to be gradually up-regulated. Three SEA treatments led to quick reduction of intracellular IL-2 expression and higher levels of IL-10, which could be maintained for at least Mice were injected three times intraperitoneally with 10 μg of SEA at different time intervals. Spleens were removed on different days after the last injection. Spleen cells were cultured with 100 ng/ml SEA, and the proliferation was examined by 3 H-TdR assay after 72 h. A stimulation index (SI)≥2 was considered to be significant proliferation. The results are from three independent experiments, with three mice used in each experiment. 14 d (Figs. 7 and 8 ).
Discussion
In this study, we have investigated the response of T cells to repeated superantigen treatments in vivo. A significant increase of T cells was seen after a single SEA injection, with the optimal dose being 10 μg, which led to the same up-regulation of CD4 + and CD8 + T cells. Several investigators have shown that the anergic state of T cells could be induced by repeated superantigen treatments [16− 18] . But controversy remained about the relationship between the number of superantigen treatments and the anergic state. Miethke et al. reported that SEB caused Lselectin down-regulation within 30 min and that SEB- △ P<0.01 compared to the same time in the 2×SEA group; ▲ P<0.01 compared with the 1×SEA group.
Fig. 7 Fluorescence-activated cell sorting (FACS) analysis of intracellular interleukin (IL)-2 after staphylococcal enterotoxin A (SEA) treatment
Mice were injected intraperitoneally various times at 3 d intervals with 10 μg of SEA. Spleens were removed at the indicated time points after the last injection. The spleen cells were fixed with 2% paraformaldehyde and permeabilized using 0.5% saponin then stained for analysis of intracellular IL-2 by FACS. Cells were gated on forward and side scatter and 5000 cells were analyzed. Representative results of three similar experiments. Vol. 39, No. 7 ©Institute of Biochemistry and Cell Biology, SIBS, CAS primed mice showed unresponsiveness to subsequent SEB challenge in vivo as early as 2−3 h after priming [19−21] . Sundstedt et al. also showed that a 7 d interval between two SEA injections resulted in proliferative hyporesponsiveness [2] . Aoki and Yoshikai showed that the second injection of SEA augmented clonal expansion of SEAreactive T cells in mice primed with SEA 2 d previously [22] . We observed that the second injection of SEA accelerated the proliferation of SEA-primed T cells in vivo. Additionally, spleen cells from mice primed by SEA could proliferate in response to SEA restimulation in vitro. These data suggested that SEA-primed T cells retain the potential to proliferate after rechallenge with SEA. However, the responsiveness of CD4 + and CD8 + T cells were affected by the time interval between injections. A short interval resulted in a quick and transitory increase of CD4 + T cells and a slow increase of CD8 + T cells. A long interval resulted in the same slow and prolonged proliferation of both subsets. There were important differences between other research and our own, such as the time interval between injections and the days observed. Our results showed the short interval resulted in down-regulation of CD4 + T cells after 3 d and no obvious increase of CD8 + T cells before 7 d after the last injection, which might lead to a different conclusion.
Previous studies showed that apart from the ability to proliferate T cells in vivo, superantigens induce a subsequent state of unresponsiveness, which include at least two different mechanisms, physical elimination (deletion) and functional inactivation (anergy) [23−26] . We observed that multiple SEA treatments at short intervals only resulted in a marked reduction in the number of CD4 + T cells followed by an anergic state. Interestingly, CD4 + and CD8 + T cells appeared unresponsive without an obvious decrease in number after three SEA treatments at long intervals. These results suggested a third SEA injection was required for induction of anergy, and the time interval between SEA treatments strongly influenced the deletion of CD4 + T cells, but not CD8 + T cells. The number of CD4 + T cells decreased following multiple SEA injections at short intervals than those at long intervals, then the remaining SEA-reactive T cells showed failure to respond in vitro. However, the unresponsiveness was reversible in vivo. Although the proliferative capability of spleen cells from the mice injected with SEA three times was gradually restored, the period for recovery was affected by the interval between injections. That is to say, the longer the interval, the longer time the anergic state would last in vivo, which hinted that we might artificially control the period of anergy of T cells. Previous studies have shown that the failure to produce normal levels of IL-2 appears to be a critical hallmark of anergy induction [27−29] . In our study, it was shown that SEA accelerated the expansion of T cells, and the activation phase was followed by unresponsiveness after repeated SEA treatments in vivo. In an effort to prove the anergic state, we examined the levels of IL-2. A single SEA injection gave rise to rapid production of IL-2, and two treatments triggered a second wave of release of intracellular IL-2. T cells were unable to produce IL-2 in response to three SEA treatments. IL-10 has been reported to be induced after repeated SEA challenges in vivo, which might act as an inhibitor to help inducing anergy [30−32] . We found IL-10 levels were opposite to the levels of IL-2. Repeated SEA challenges resulted in a stable up-regulation of IL-10 production, and high levels of IL-10 were released by anergic T cells after last injection. These results were not only in accordance with previous studies, but also suggested IL-10 was related to the maintenance of anergy.
In conclusion, this study showed that both CD4 + and CD8 + SEA-primed T cells have the responsiveness to SEA rechallenge in vivo, and a third injection was required to induce the anergy of T cells. The time interval between injections played an important role in the response of CD4 + and CD8 + T cells. The relationship between IL-2 and IL-10 might reflect the response of T cells to superantigens.
